iollo is a Stanford spinout, co-founded with Prof. Michael Snyder and backed by Y Combinator. We developed Quinn, an AI scientist built to rapidly accelerate pharma and biotech discovery.

Quinn quickly integrates and analyzes complex multi-omics and clinical datasets, autonomously uncovering novel biology, actionable therapeutic targets, and robust mechanistic insights — compressing critical steps like target identification, lead optimization (biological and chemical), translational analysis, and risk assessment from months to days.

For biotech companies and pharma teams, Quinn streamlines data-driven decisions, reduces development risk, and optimizes strategic investments without the need for additional internal resources or headcount.